| |
| |
|
| Insider
Information: |
Tisch Thomas J |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,748,764 |
|
|
Indirect Shares
|
3,343,463 |
|
|
| Direct
Value |
$6,181,956 |
|
|
|
Indirect Value
|
$73,347,258 |
|
|
| Total
Shares |
5,092,227 |
|
|
| Total
Value |
$79,529,214 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adamis Pharmaceuticals Corp |
ADMP |
10% Owner |
2005-05-12 |
897,163 |
2005-05-12 |
899,422 |
Premium* |
|
|
Incyte Corp |
INCY |
No longer 10% owner. |
2004-08-12 |
117,592 |
2004-08-12 |
1,416,661 |
Premium* |
|
|
Synageva BioPharma Corp |
GEVA |
Director |
2015-06-22 |
0 |
2015-06-22 |
0 |
Premium* |
|
|
Sears Holdings Corp |
SHLD |
Director |
2017-01-10 |
734,009 |
2017-01-10 |
1,027,380 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SHLD |
Sears Holdings Corp |
Director |
– • – |
2017-01-10 |
4 |
A |
$0.00 |
$0 |
I/I |
119,908 |
1,027,380 |
0 |
- |
|
| SHLD |
Sears Holdings Corp |
Director |
– • – |
2017-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
113,185 |
734,009 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
Director |
– • – |
2015-06-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(378,435) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
Director |
– • – |
2015-06-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(373,560) |
0 |
0 |
- |
|
| SHLD |
Sears Holdings Corp |
Director |
– • – |
2014-04-16 |
4 |
B |
$33.40 |
$3,340,000 |
D/D |
100,000 |
620,824 |
2.39 |
- |
|
| SHLD |
Sears Holdings Corp |
Director |
– • – |
2014-04-15 |
4 |
B |
$33.60 |
$12,600,000 |
D/D |
375,000 |
520,824 |
2.39 |
- |
|
| GEVA |
Synageva BioPharma Corp |
Director |
– • – |
2013-01-09 |
4 |
B |
$47.53 |
$999,984 |
I/I |
21,039 |
373,560 |
2.1 |
- |
|
| GEVA |
Synageva BioPharma Corp |
Director |
– • – |
2012-07-12 |
4 |
B |
$41.20 |
$1,503,800 |
D/D |
36,500 |
378,435 |
2.39 |
- |
|
| GEVA |
Synageva BioPharma Corp |
Director |
– • – |
2012-07-12 |
4 |
B |
$41.20 |
$1,503,800 |
I/I |
36,500 |
352,521 |
2.1 |
- |
|
| GEVA |
Synageva BioPharma Corp |
10% Owner |
– – • |
2012-01-10 |
4 |
B |
$25.18 |
$30,216,000 |
D/D |
1,200,000 |
341,935 |
2.45 |
- |
|
| GEVA |
Synageva BioPharma Corp |
10% Owner |
– – • |
2011-11-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
316,021 |
|
- |
|
| GEVA |
Synageva BioPharma Corp |
10% Owner |
– – • |
2011-11-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
221,935 |
|
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
10% Owner |
– – • |
2005-05-12 |
4 |
B |
$0.00 |
$0 |
I/I |
644,000 |
899,422 |
1.42 |
- |
|
| INCY |
Incyte Corp |
10% Owner |
– – • |
2004-08-12 |
4 |
B |
$5.50 |
$1,406,625 |
I/I |
255,750 |
1,416,661 |
1.5 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
10% Owner |
– – • |
2004-07-27 |
4 |
B |
$3.42 |
$512,850 |
I/I |
150,000 |
782,208 |
1.5 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
